Timothy Trysla

Timothy Trysla

Alston & Bird

Contact

Readers' Choice Awards

Healthcare
Healthcare
Healthcare
Healthcare
View Bio
RSS

Latest Posts › Drug Pricing

Share:

Health Care Week in Review: IRA Guidance and ESRD PPS Rule

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

7/3/2023  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Pharmaceutical Industry , Popular , Prescription Drugs

Health Care Week in Review: HHS Issued Proposed Rules and a Request for Information

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

12/6/2022  /  Affordable Care Act , Centers for Disease Control and Prevention (CDC) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Popular , Section 340B

Alston & Bird Health Care Week in Review - December 2020 #2

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

12/14/2020  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Medicare , Pharmaceutical Industry , Prescription Drugs , Section 340B , Vaccinations

Alston & Bird Healthcare Week in Review

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

12/16/2019  /  Centers for Medicare & Medicaid Services (CMS) , Drug Pricing , FDA Reauthorization Act , Food and Drug Administration (FDA) , GAO , Health Care Providers , Pharmaceutical Industry

Alston & Bird Healthcare Week in Review

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

9/30/2019  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medical Device User Fee Program (MDUFA IV) , Medical Devices , Medicare , Pharmaceutical Industry , Prescription Drugs

Alston & Bird Healthcare Week in Review

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

9/16/2019  /  Centers for Medicare & Medicaid Services (CMS) , Controlled Substances Act , DEA , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medical Device User Fee Program (MDUFA IV) , Medical Devices , Medicare , Pharmaceutical Industry , Prescription Drugs , SAMHSA

Alston & Bird Healthcare Week in Review

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

7/15/2019  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Pharmaceutical Industry , Prescription Drugs , REMS , Trump Administration
32 Results
 / 
View per page
« Previous
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide